4.6 Article

Comprehensive Re-Sequencing of Adrenal Aldosterone Producing Lesions Reveal Three Somatic Mutations near the KCNJ5 Potassium Channel Selectivity Filter

期刊

PLOS ONE
卷 7, 期 7, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0041926

关键词

-

资金

  1. Swedish Cancer Society
  2. Swedish Research Council
  3. Swedish Society for Medical Research
  4. Ake Wiberg Foundation
  5. Selander Foundation
  6. Jeanssons Foundation
  7. Leducq Transatlantic Network for Hypertension

向作者/读者索取更多资源

Background: Aldosterone producing lesions are a common cause of hypertension, but genetic alterations for tumorigenesis have been unclear. Recently, either of two recurrent somatic missense mutations (G151R or L168R) was found in the potassium channel KCNJ5 gene in aldosterone producing adenomas. These mutations alter the channel selectivity filter and result in Na+ conductance and cell depolarization, stimulating aldosterone production and cell proliferation. Because a similar mutation occurs in a Mendelian form of primary aldosteronism, these mutations appear to be sufficient for cell proliferation and aldosterone production. The prevalence and spectrum of KCNJ5 mutations in different entities of adrenocortical lesions remain to be defined. Materials and Methods: The coding region and flanking intronic segments of KCNJ5 were subjected to Sanger DNA sequencing in 351 aldosterone producing lesions, from patients with primary aldosteronism and 130 other adrenocortical lesions. The specimens had been collected from 10 different worldwide referral centers. Results: G151R or L168R somatic mutations were identified in 47% of aldosterone producing adenomas, each with similar frequency. A previously unreported somatic mutation near the selectivity filter, E145Q, was observed twice. Somatic G151R or L168R mutations were also found in 40% of aldosterone producing adenomas associated with marked hyperplasia, but not in specimens with merely unilateral hyperplasia. Mutations were absent in 130 non-aldosterone secreting lesions. KCNJ5 mutations were overrepresented in aldosterone producing adenomas from female compared to male patients (63 vs. 24%). Males with KCNJ5 mutations were significantly younger than those without (45 vs. 54, respectively; p < 0.005) and their APAs with KCNJ5 mutations were larger than those without (27.1 mm vs. 17.1 mm; p < 0.005). Discussion: Either of two somatic KCNJ5 mutations are highly prevalent and specific for aldosterone producing lesions. These findings provide new insight into the pathogenesis of primary aldosteronism.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors

Kazhan Mollazadegan, Britt Skogseid, Johan Botling, Tobias Akerstrom, Barbro Eriksson, Staffan Welin, Anders Sundin, Joakim Crona

Summary: This retrospective study investigated the treatment patterns and outcomes for patients with secondary panNET-G3. The results found that both platinum-etoposide chemotherapy and conventional panNET therapies had relatively short median overall survival and progression-free survival. The study highlights the challenges in treating this type of tumor.

ENDOCRINE CONNECTIONS (2022)

Meeting Abstract Oncology

KRAS-G12C NSCLC linked to female sex and high risk of CNS metastasis: Real-world data from the National Swedish Lung Cancer Registry 2016-2019

J. Isaksson, A. Berglund, K. Louie, A. Hamidian, A. Edsjo, M. Johansson, A. Hallqvist, G. Wagenius, L. Willen, J. Botling

ANNALS OF ONCOLOGY (2022)

Article Oncology

Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma

Anand Khadse, Vilde D. Haakensen, Laxmi Silwal-Pandit, Julian Hamfjord, Patrick Micke, Johan Botling, Odd Terje Brustugun, Ole Christian Lingjaerde, Aslaug Helland, Elin H. Kure

Summary: LOH in KRAS is associated with prognosis in early-stage lung adenocarcinoma, especially in cases with mutations. Patients with both KRAS mutation and LOH have a better prognosis compared to those with only KRAS mutation.

FRONTIERS IN ONCOLOGY (2022)

Article Surgery

Minimally invasive video-assisted parathyroidectomy (MIVAP) versus conventional parathyroidectomy for renal hyperparathyroidism: a retrospective multicenter study

Iurii Snopok, Richard Viebahn, Martin Walz, Panagiota Zgoura, Pier Francesco Alesina

Summary: This study compared the outcomes of minimally invasive video-assisted parathyroidectomy (MIVAP) and conventional surgery for renal hyperparathyroidism (rHPT). The results showed that MIVAP had a smaller incision, shorter operation duration, and shorter duration of stay compared to conventional surgery, but had a smaller drop in postoperative parathyroid hormone (PTH) levels. MIVAP was superior to conventional surgery in terms of aesthetic outcomes and cost effectiveness, while conventional surgery showed better control of PTH levels and health scores on follow-up.

UPDATES IN SURGERY (2022)

Article Surgery

Preoperative prophylactic active vitamin D to streamline total thyroidectomy

Matilda Anneback, Edward McHale Sjodin, Per Hellman, Peter Stalberg, Olov Norlen

Summary: This retrospective cohort study investigated the potential benefit of preoperative active vitamin D supplementation on hypocalcaemia and its symptoms after thyroidectomy. The study found that preoperative alfacalcidol treatment was associated with reduced biochemical hypocalcaemia and duration of hospital stay.

BJS OPEN (2022)

Review Endocrinology & Metabolism

Targeted Therapies in Pheochromocytoma and Paraganglioma

Katharina Wang, Joakim Crona, Felix Beuschlein, Ashley B. Grossman, Karel Pacak, Svenja Noelting

Summary: Molecular targeted therapy plays an important role in the treatment of metastatic pheochromocytomas and paragangliomas. Some therapies are already in use with promising results, while others are still under evaluation in clinical trials. The development of molecular targeted therapies is of great significance for future tumor treatment.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Oncology

Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features

Teijo Pellinen, Lassi Paavolainen, Alfonso Martin-Bernabe, Renata Papatella Araujo, Carina Strell, Artur Mezheyeuski, Max Backman, Linnea La Fleur, Oscar Bruck, Jonas Sjolund, Erik Holmberg, Katja Valimaki, Hans Brunnstrom, Johan Botling, Pablo Moreno-Ruiz, Olli Kallioniemi, Patrick Micke, Arne Ostman

Summary: This study used multiplex fluorescence immunohistochemistry to study the tumor microenvironment in non-small cell lung cancer (NSCLC) and identified multiple cancer-associated fibroblast (CAF) subsets. The results showed that CAFs play a significant role in NSCLC progression and may have potential as biomarkers or therapeutic targets.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Surgery

Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation

Josefine Kjaer, Sara Smith, Per Hellman, Peter Stalberg, Joakim Crona, Staffan Welin, Olov Norlen

Summary: This study aimed to determine the survival rates of patients with stage IV neuroendocrine pancreatic tumors who met the criteria for liver transplantation. The results showed a 5-year survival rate of 64.7% for stage IV pan-NET patients, and the survival rates for patients meeting the Milan, ENETS, and UNOS criteria were 64.9%, 85.7%, and 55.4% respectively.

WORLD JOURNAL OF SURGERY (2023)

Article Endocrinology & Metabolism

Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis

Suman Ghosal, Katerina Hadrava Vanova, Ondrej Uher, Shaoli Das, Mayank Patel, Leah Meuter, Thanh-Truc Huynh, Abhishek Jha, Sara Talvacchio, Marianne Knue, Tamara Prodanov, Martha A. Zeiger, Naris Nilubol, David Taieb, Joakim Crona, Uma T. Shankavaram, Karel Pacak

Summary: In this study, we analyzed transcriptomic data from NENs to identify immune cell infiltration signatures, particularly in PCPG. We validated the immune signature of PCPG using an independent cohort. We identified five dominant immune clusters in PCPG, associated with different immune cell types. Furthermore, we developed a prognostic immune score model that could predict non-aggressive and non-metastatic diseases.

ENDOCRINE (2023)

Meeting Abstract Oncology

Defining Morphologic Features of Invasion in Pulmonarynon-Mucinousadenocarcinoma with Lepidic Growth

E. Thunnissen, A. Borczuk, M. B. Beasly, M. Tsao, K. Kerr, S. Dacic, Y. Minami, A. Nicholson, B. Lissenberg-Witte, A. Roden, M. Papotti, C. Poleri, B. Travis, D. Jain, G. Pelosi, J. H. Chung, J. Botling, L. Bubendorf, M. Mino-Kenudson, N. Motoi, S. Lantuejoul, W. Cooper, D. Hwang, A. Moreira, M. Noguchi

JOURNAL OF THORACIC ONCOLOGY (2022)

Meeting Abstract Oncology

The Role of Stromal PDGFRβ-activation in NSCLC

A. Lindberg, A. Grandon, H. Yu, V. Thurfjell, A. Cederholm, A. Klemm, H. Brunnstrom, J. Botling, P. Micke, C. Strell

JOURNAL OF THORACIC ONCOLOGY (2022)

Meeting Abstract Oncology

Tracking ROS1 Fusions in NSCLC - Mirage or Truth When Screening the Desert

J. Mattsson, V. Thurfjell, T. Goldmann, R. Krupar, H. Brunnstrom, K. Lamberg, M. Gulyas, J. Botling, P. Micke

JOURNAL OF THORACIC ONCOLOGY (2022)

Meeting Abstract Oncology

Multiplex Phenotyping Reveals Spatial Immune Patterns in NSCLC

M. Backman, H. Elfving, H. Brunnstrom, J. S. M. Mattsson, J. Isaksson, L. La Fleur, K. Karre, F. Ponten, K. Lamberg, C. Lindskog, M. Gulyas, C. Strell, J. Botling, A. Mezheyeuski, P. Micke

JOURNAL OF THORACIC ONCOLOGY (2022)

Meeting Abstract Oncology

Can Genotype Predict Metastasis/recurrence in SDHB Mutant Pheochromocytoma/paragangliomas

Tahsin M. Khan, Elizabeth A. Hedges, Alexander Rossi, Tamara Prodanov, Henri Timmers, Joakim Crona, Tobias Akerstrom, Karel Pacak, Naris Nilubol

ANNALS OF SURGICAL ONCOLOGY (2022)

暂无数据